Molecular Guided Therapy for Advanced Pancreatic Cancer Patients With PI3K Activated Mutation: Vision or Illusion?

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s38520
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Antiangiogenic Cancer Therapy Using Peptide Vaccine for Patients With Advanced Pancreatic Cancer

Suizo
2010English

Endoscopic Ultrasound-Guided Intratumoural Therapy for Pancreatic Cancer

Canadian Journal of Gastroenterology
2008English

Stereotactic MR-Guided Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Tumors

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Detection ofTP53R249 Mutation in Iranian Patients With Pancreatic Cancer

Journal of Oncology
Oncology
2013English

Neoadjuvant FOLFIRINOX for Patients With Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis

Oncologist
Cancer ResearchMedicineOncology
2019English

CT-guided Percutaneous Irreversible Electroporation for Patients With Locally Advanced Pancreatic Cancer Who Are Unable to Tolerate Periodic Standard Chemotherapy

HPB
HepatologyGastroenterology
2018English

Expandable Metallic Stent to Patients With the Locally Advanced or Recurrent Cholangiocarcinoma, Gallbladder Cancer and Pancreatic Cancer.

Japanese Journal of Gastroenterological Surgery
SurgeryGastroenterology
2001English

Targeted Therapy for Advanced Prostate Cancer: Inhibition of the PI3K/Akt/mTOR Pathway

Current Cancer Drug Targets
Cancer ResearchDrug DiscoveryOncologyPharmacology
2009English

Molecular Profiling of Pancreatic Cancer Patients—Letter

Clinical Cancer Research
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy